MT-1 vs MT-2: Structure, Receptor Research and Analytical Differences
MT-1 and MT-2 are often grouped together because both are synthetic analogues developed from alpha-melanocyte-stimulating hormone (α-MSH). They are not, however, interchangeable names for the same compound. Their peptide architecture, receptor-research profiles and analytical identification requirements differ.
This guide separates those differences for laboratory researchers. It does not provide dosing, administration or personal-use information.
What is MT-1?
MT-1 is commonly used as a shorthand for Melanotan I, also known in pharmaceutical research as afamelanotide. It is a linear analogue of α-MSH. Amino-acid substitutions were introduced to make the sequence more resistant to rapid enzymatic breakdown than the endogenous hormone.
Because MT-1 is linear, its exact sequence, terminal form and molecular mass are central identity markers. A label that says only “melanocortin peptide” is not enough to establish identity.
What is MT-2?
MT-2, or Melanotan II, is a shorter cyclic melanocortin analogue. Its lactam ring constrains the peptide into a different three-dimensional shape. That structural constraint is one reason MT-2 is studied across a broader melanocortin-receptor profile.
The cyclic structure also changes what a laboratory should expect from mass-spectrometric identity testing. MT-2 therefore cannot be verified simply by comparing it with an MT-1 chromatogram.
MT-1 vs MT-2 at a glance
| Feature | MT-1 | MT-2 |
|---|---|---|
| General architecture | Linear peptide analogue | Cyclic peptide analogue |
| Common research name | Melanotan I / afamelanotide | Melanotan II |
| Analytical distinction | Sequence and terminal form must match the stated linear compound | Identity must account for the cyclic lactam structure |
| Receptor research | Studied primarily in melanocortin pathways | Studied across a broader melanocortin-receptor profile |
What should analytical testing show?
HPLC can estimate chromatographic purity, but a high HPLC percentage does not by itself prove that the material is MT-1 or MT-2. Identity testing by mass spectrometry should produce data consistent with the expected molecular species. Researchers should check that the report identifies the exact compound and batch rather than relying on a generic certificate.
A useful certificate of analysis should include the sample or batch identifier, analytical method, date, numerical result and laboratory identity. Learn more in our guides to peptide testing and verification and batch traceability.
Why terminology creates confusion
Search results and informal discussions sometimes use “melanotan” without specifying which analogue is meant. That ambiguity matters. A defensible research record should use the full compound name, the exact sequence or formula supplied by the manufacturer, and the batch reference shown on the analytical report.
Research materials
ZENTRA lists separate research materials for MT-1 and MT-2. Each should be assessed against its own batch documentation; one compound’s analytical result must never be treated as evidence for the other.
Frequently asked questions
Are MT-1 and MT-2 the same peptide?
No. They are related melanocortin analogues, but MT-1 is linear and MT-2 is cyclic, with different sequences and analytical identities.
Does HPLC alone identify MT-1 or MT-2?
No. HPLC purity and mass-spectrometric identity answer different questions. Both are valuable when assessing a peptide batch.
Can the two names be used interchangeably?
No. Laboratory records should state the exact analogue to avoid ambiguity.
Further reading
Research-use notice: This article is educational laboratory information only. ZENTRA research compounds are not for human or veterinary use.
